arrow
J

Jan-Stephan Sanders

University of Groningen
H指数:46
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Donor anti-cytomegalovirus IgG titer and risk of cytomegalovirus infection after D+R- kidney transplantation, results from the TransplantLines Biobank and Cohort Study

供者抗巨细胞病毒IgG滴度与D+R-肾移植后巨细胞病毒感染风险的关系:来自TransplantLines生物库和队列研究的结果

2026-07-010
OAAI
Unveiling Donor-Derived BKPyV DNAemia Through Analysis of Contralateral Kidney Transplant Recipients

通过分析对侧肾脏移植受者揭示供体衍生的BKPyV DNA血症

2026-04-040
OA
Comparable outcomes for old, older and very old deceased donors in old kidney transplant recipients

老年肾移植受者中,来自老年、高龄及极高龄 deceased donors 的可比移植结果

2026-01-100
OAAI
Torque Teno Virus Loads and Leukocyte Populations in Stable Outpatient Solid Organ Transplant Recipients

torque teno病毒载量与稳定门诊实体器官移植受者的白细胞群体

2025-11-130
OAAI
Organ Donor Potential After Extracorporeal Cardiopulmonary Resuscitation for Out-of-Hospital Cardiac Arrest: A Post-Hoc Analysis of a Randomized Controlled Trial

院外心脏骤停体外心肺复苏后器官供体潜力: 一项随机对照试验的事后分析

2025-11-010
OAAI
Repeated HLA-DRB1 and HLA-DQB1 Mismatches Without Preformed DSA Affect Graft Survival, Rejection and DSA Development: A Multicenter Analysis

重复的HLA-DRB1和HLA-DQB1错配在没有预存DSA的情况下影响移植物存活、排斥反应和DSA发展:一项多中心分析

HLA
IF4.1
2025-05-190
OA
Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial
2025-04-010
PRE
Letter to the Editor in Response to Paper Peptide Sharing Between CMV and Mismatched HLA Class I Peptides Promotes Early T- Cell-Mediated Rejection After Kidney Transplantation

致编辑的信:对论文《Peptide Sharing Between CMV and Mismatched HLA Class I Peptides Promotes Early T-Cell-Mediated Rejection After Kidney Transplantation》的回应

HLA
IF4.1
2025-02-240
PRE
Repeated COVID-19 Vaccination Drives Memory T- and B-cell Responses in Kidney Transplant Recipients: Results From a Multicenter Randomized Controlled Trial
2024-11-210
OAAI